Randomized double-blind control clinical study of lower-risk myelodysplastic syndrom (kideny Yang Deficiency) of compound Shenlu granule

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) Patients aged 18-80 years (calculated by date of birth);
•(2) The diagnostic criteria of MDS in Vienna in 2006 were met,
•(3) IPSS risk score was low / medium risk-1 (<= 1.0), and ipss-r was extremely low-risk / low-risk / medium risk (<= 3.5);
•(4) Patients who met the diagnostic criteria of kidney yang deficiency syndrome;
•(5)HGB<100g/L;
•(6) No other drugs that may affect hematopoietic function were used for 3 months or more;
•(7) The subjects were volunteers and informed consent was signed.

•(1) Pregnant and lactating women;
•(2) Those with allergic constitution are allergic to the test drug or its related drugs or ingredients;
•(3) Patients with severe primary diseases such as heart, cerebrovascular, liver and kidney diseases;
•(4) Patients with severe liver function damage had ALT or AST >= 1.5 times of the upper limit of normal value;
•(5) In patients with severe renal impairment, serum creatinine was more than 1.5 times of the upper limit of normal value;
•(6) Mental illness patients who can't cooperate with each other;
•(7) Those who are participating in other clinical trials or have participated in other drug clinical trials within 3 months.

发起方

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine